Piedmont Investment Advisors’s Guardant Health GH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-3,327
Closed -$232K 275
2020
Q1
$232K Buy
3,327
+536
+19% +$41.1K 0.01% 688
2019
Q4
$218K Buy
+2,791
New +$201K 0.01% 869
2019
Q3
Sell
-2,542
Closed -$219K 910
2019
Q2
$219K Buy
+2,542
New +$194K 0.01% 878

Other funds holding GH

Piedmont Investment Advisors's GH Position: Q2 2020 in Review

Piedmont Investment Advisors sold out of Guardant Health (GH) in Q2 2020, closing a stake of 3,327 shares — an estimated $232K sold.

Piedmont Investment Advisors first reported a position in GH in Q2 2019 and held it in 3 quarters. The position peaked at $232K in Q1 2020. 325 funds tracked by Wall St. Rank hold GH as of Q2 2020.

  • Piedmont Investment Advisors reported no remaining Guardant Health position as of Q2 2020 after selling out during the quarter.
  • Piedmont Investment Advisors sold 3,327 Guardant Health shares in Q2 2020, an estimated $232K.
  • Piedmont Investment Advisors first reported a position in Guardant Health in Q2 2019 and held it in 3 quarters.
  • Piedmont Investment Advisors's Guardant Health position peaked at $232K in Q1 2020.
  • 325 funds tracked by Wall St. Rank held Guardant Health as of Q2 2020.

Based on Piedmont Investment Advisors's 13F filing for Q2 2020.